Vivimed Labs Ltd (VIVIMEDLAB):企業の財務・戦略的SWOT分析

◆英語タイトル:Vivimed Labs Ltd (VIVIMEDLAB) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA8012831
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月29日
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Vivimed Labs Ltd (VIVIMEDLAB) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Vivimed Labs Ltd (Vivimed) is a supplier of niche molecules and formulations to healthcare, pharmaceuticals and specialty chemicals customers across the world. The company provides active pharmaceutical ingredients (APIs), finished dosage formulations, and specialty chemicals. It manufactures and supplies APIs for hair, skin, oral care; and anti-microbial preservatives for home and personal care market. The company offers contract manufacturing services and the manufacture of branded formulations. It offers a comprehensive range of hair dye intermediates for permanent, semi-permanent and temporary hair coloring, photo chromic dyes, and imaging chemicals. It has presence in India, China, Mauritius, the UK, the US, Spain, and Mexico. Vivimed is headquartered in Hyderabad, Telangana, India.

Vivimed Labs Ltd Key Recent Developments

Sep 21,2017: Vivimeds FDF Facility In Jeedimetla Obtained Ukraine GMP Approval
Jun 06,2017: Vivimed Labs Provides Update on USFDA Inspection at UQUIFA’s Facility
Nov 29,2016: Vivimed’s FDF facllity in Alathur completed successful USFDA inspection
Apr 25,2016: Vivimed appoints Pavan Kumar as CEO
Apr 25,2016: Vivimed appoints M. Pavan Kumar as new CEO

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Vivimed Labs Ltd – Key Facts 5
Vivimed Labs Ltd – Key Employees 6
Vivimed Labs Ltd – Key Employee Biographies 7
Vivimed Labs Ltd – Major Products and Services 8
Vivimed Labs Ltd – History 9
Vivimed Labs Ltd – Company Statement 10
Vivimed Labs Ltd – Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2 – Company Analysis 14
Vivimed Labs Ltd – Business Description 14
Vivimed Labs Ltd – Corporate Strategy 15
Vivimed Labs Ltd – SWOT Analysis 16
SWOT Analysis – Overview 16
Vivimed Labs Ltd – Strengths 16
Vivimed Labs Ltd – Weaknesses 17
Vivimed Labs Ltd – Opportunities 18
Vivimed Labs Ltd – Threats 19
Vivimed Labs Ltd – Key Competitors 20
Section 3 – Company Financial Ratios 21
Financial Ratios – Capital Market Ratios 21
Financial Ratios – Annual Ratios 22
Performance Chart 25
Financial Performance 25
Financial Ratios – Interim Ratios 26
Financial Ratios – Ratio Charts 27
Section 4 – Company’s Lifesciences Financial Deals and Alliances 28
Vivimed Labs Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 28
Vivimed Labs Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 29
Vivimed Labs Ltd, Recent Deals Summary 30
Section 5 – Company’s Recent Developments 31
Sep 21, 2017: Vivimeds FDF Facility In Jeedimetla Obtained Ukraine GMP Approval 31
Jun 06, 2017: Vivimed Labs Provides Update on USFDA Inspection at UQUIFA’s Facility 32
Nov 29, 2016: Vivimed’s FDF facllity in Alathur completed successful USFDA inspection 33
Section 6 – Appendix 34
Methodology 34
Ratio Definitions 34
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Vivimed Labs Ltd, Key Facts 5
Vivimed Labs Ltd, Key Employees 6
Vivimed Labs Ltd, Key Employee Biographies 7
Vivimed Labs Ltd, Major Products and Services 8
Vivimed Labs Ltd, History 9
Vivimed Labs Ltd, Other Locations 12
Vivimed Labs Ltd, Subsidiaries 12
Vivimed Labs Ltd, Key Competitors 20
Vivimed Labs Ltd, Ratios based on current share price 21
Vivimed Labs Ltd, Annual Ratios 22
Vivimed Labs Ltd, Annual Ratios (Cont...1) 23
Vivimed Labs Ltd, Annual Ratios (Cont...2) 24
Vivimed Labs Ltd, Interim Ratios 26
Vivimed Labs Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 28
Vivimed Labs Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 29
Vivimed Labs Ltd, Recent Deals Summary 30
Currency Codes 34
Capital Market Ratios 34
Equity Ratios 35
Profitability Ratios 35
Cost Ratios 36
Liquidity Ratios 36
Leverage Ratios 37
Efficiency Ratios 37

★海外企業調査レポート[Vivimed Labs Ltd (VIVIMEDLAB):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CFM International, Inc.:企業の戦略・SWOT・財務情報
    CFM International, Inc. - Strategy, SWOT and Corporate Finance Report Summary CFM International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Proximus SA (formerly Belgacom SA):企業のM&A・事業提携・投資動向
    Proximus SA (formerly Belgacom SA) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Proximus SA (formerly Belgacom SA) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on m …
  • Edcon Holdings (Proprietary) Limited:企業の戦略・SWOT・財務情報
    Edcon Holdings (Proprietary) Limited - Strategy, SWOT and Corporate Finance Report Summary Edcon Holdings (Proprietary) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Ingram Micro Inc:企業の戦略的SWOT分析
    Ingram Micro Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Companhia Energetica de Minas Gerais – CEMIG:企業の戦略・SWOT・財務分析
    Companhia Energetica de Minas Gerais - CEMIG - Strategy, SWOT and Corporate Finance Report Summary Companhia Energetica de Minas Gerais - CEMIG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Teradata Corp (TDC):企業の財務・戦略的SWOT分析
    Teradata Corp (TDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • ASFINAG:企業の戦略・SWOT・財務情報
    ASFINAG - Strategy, SWOT and Corporate Finance Report Summary ASFINAG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Largo Resources Ltd.:企業のM&A・事業提携・投資動向
    Largo Resources Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Largo Resources Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • U.S. Neurosurgical Inc (USNU):企業の財務・戦略的SWOT分析
    Summary U.S. NeuroSurgical Inc (USN) is a medical service company that provides biotechnology and neurosurgery services. The company assists and facilitates medical device manufacturers in gaining access and entry into the US neurosurgical marketplace. It provides treatment services such as gamma kn …
  • Covance Inc-製薬・医療分野:企業M&A・提携分析
    Summary Covance Inc (Covance), a subsidiary of LabCorp, is a drug development company that offers contract research and manufacturing services. The company offers a broad range of early-stage and late-stage product development services to pharmaceutical, biotechnology and medical device companies. I …
  • Hydro-Electric Corporation-エネルギー分野:企業M&A・提携分析
    Summary Hydro-Electric Corporation (Hydro Tasmania) is a state-owned clean energy company that generates, trades and sells power; sells natural gas; and provides consulting services. It generates electricity using various energy sources such as water, wind and natural gas. The company sells the elec …
  • Inter Pipeline Ltd (IPL):企業の財務・戦略的SWOT分析
    Inter Pipeline Ltd (IPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Osiris Therapeutics Inc (OSIR):企業の財務・戦略的SWOT分析
    Osiris Therapeutics Inc (OSIR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Inabata & Co Ltd (8098):企業の財務・戦略的SWOT分析
    Inabata & Co Ltd (8098) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Banco Occidental de Descuento:企業の戦略・SWOT・財務情報
    Banco Occidental de Descuento - Strategy, SWOT and Corporate Finance Report Summary Banco Occidental de Descuento - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Endo Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Endo Pharmaceuticals Inc (Endo Pharmaceuticals), a subsidiary of Endo International plc is a healthcare products provider that offers medicinal products. The company manufactures and distributes generic pharmaceutical products and over-the-counter medications. Its products include testostero …
  • Society for Worldwide Interbank Financial Telecommunication:企業の戦略的SWOT分析
    Society for Worldwide Interbank Financial Telecommunication - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, k …
  • Impact Developer & Contractor SA:企業の戦略・SWOT・財務情報
    Impact Developer & Contractor SA - Strategy, SWOT and Corporate Finance Report Summary Impact Developer & Contractor SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Intec Pharma Ltd (NTEC):製薬・医療:M&Aディール及び事業提携情報
    Summary Intec Pharma Ltd (Intec Pharma) is a biopharmaceutical company that offers delivery solutions for drugs. The company’s pipeline products include drug indications for Parkinson’s disease, insomnia and other diseases. Its proprietary gastro retentive formulation, offers a drug delivery solutio …
  • Goodman Fielder Pty Ltd:企業の戦略・SWOT・財務情報
    Goodman Fielder Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Goodman Fielder Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆